Bye Bye DEI

anonymous

Guest
The country has spoken. No more biological males competing in Women's sports. No more promotions based on anything other than ability. We can do our part by getting rid of the silly virtue signaling pronouns. Get ready for the new golden age of America. It's gonna be HUGE.
 




The country has spoken. No more biological males competing in Women's sports. No more promotions based on anything other than ability. We can do our part by getting rid of the silly virtue signaling pronouns. Get ready for the new golden age of America. It's gonna be HUGE.
Amazing! Now I can finally speak again without being cancelled. Nothing wrong with referring to female colleagues as sugar and sweetheart when I tell them to get me coffee. Happy days are here again!
 




The country has spoken. No more biological males competing in Women's sports. No more promotions based on anything other than ability. We can do our part by getting rid of the silly virtue signaling pronouns. Get ready for the new golden age of America. It's gonna be HUGE.
Well stated! Most out here in the field laughed and laughed and laughed when we'd see the virtue signaling pronouns under the signature line of emails coming out of the wokeabies in the home office. Let's drop the pronouns and just get the goals and sales reporting numbers right. What do you posers in the home office think about that? Put the pathetic DEI away and Let's just get these good drugs out to the appropriate people that will benefit from them. DEI was sooooooo distracting. Put away the race baiting too while your at it. It didn't work for Kamala and it didn't work for Alkermes.
 












Well stated! Most out here in the field laughed and laughed and laughed when we'd see the virtue signaling pronouns under the signature line of emails coming out of the wokeabies in the home office. Let's drop the pronouns and just get the goals and sales reporting numbers right. What do you posers in the home office think about that? Put the pathetic DEI away and Let's just get these good drugs out to the appropriate people that will benefit from them. DEI was sooooooo distracting. Put away the race baiting too while your at it. It didn't work for Kamala and it didn't work for Alkermes.
Love this post!
 








Problem is you said Good Drugs, Alkermes doesn’t have a single good drug. Vivitrol has been dead for years because of incompetent leadership.
Vivitrol isn't dead because of incompetent leadership. It isn't dead at all...but it is on life-support. Like every other medication ever created, it has run its life-cycle, and revenue growth has plateaued. "Leadership" can't improve its effectiveness nor can "Leadership" create another indication. And those are the two biggest limiting factors to revenue growth. Sales has done an excellent job in spreading the gospel...virtually every prescriber in the addiction space knows about it...so there isn't any low-hanging...or even medium-hanging, fruit left to pick.

Where leadership dropped the ball was in assuming the growth we got in the initial years after the OUD indication was going to last forever...and then growing headcount based on that assumption. They dropped the ball by not creating a detox protocol + kit to help pts get through detox. They dropped the ball by not partnering with the Bridge for detox. They dropped the ball by not developing a legal, effective, DTC campaign. Now, that doesn't mean that didn't try each of the tactics...they may have. But they didn't produce any of them.

I've heard criticism that they should have done more studies...assuming those studies would have produced more compelling results. But my guess is they did do additional studies...and the results weren't sufficient enough to warrant publication.
 




Vivitrol isn't dead because of incompetent leadership. It isn't dead at all...but it is on life-support. Like every other medication ever created, it has run its life-cycle, and revenue growth has plateaued. "Leadership" can't improve its effectiveness nor can "Leadership" create another indication. And those are the two biggest limiting factors to revenue growth. Sales has done an excellent job in spreading the gospel...virtually every prescriber in the addiction space knows about it...so there isn't any low-hanging...or even medium-hanging, fruit left to pick.

Where leadership dropped the ball was in assuming the growth we got in the initial years after the OUD indication was going to last forever...and then growing headcount based on that assumption. They dropped the ball by not creating a detox protocol + kit to help pts get through detox. They dropped the ball by not partnering with the Bridge for detox. They dropped the ball by not developing a legal, effective, DTC campaign. Now, that doesn't mean that didn't try each of the tactics...they may have. But they didn't produce any of them.

I've heard criticism that they should have done more studies...assuming those studies would have produced more compelling results. But my guess is they did do additional studies...and the results weren't sufficient enough to warrant publication.
I think they were too preoccupied with putting their energy into distracting DEI initiatives that inhibited proper execution of any marketing strategies.
 








I think they were too preoccupied with putting their energy into distracting DEI initiatives that inhibited proper execution of any marketing strategies.
Perhaps...but the revenue growth was slowing long before any DEI initiatives. Marketing in pharma is severely curtailed by the FDA...approved claims only and all that. But more importantly, Vivitrol is only moderately effective for OUD and AUD in the real world...and prescribers know it. You can't market your way around what they experience.

Certainly DEI was a distraction....but from what?
What stellar marketing campaign got pushed aside for DEI?
What DTC campaign got pushed aside for DEI?
What detox kit got pushed aside for DEI?

Well...none. If DEI never existed ALKS would still be suffering from weak revenue growth. DEI is no more to blame for weak growth than the KAMs were. Both were rightly questioned and eventually curtailed\rejected...but neither was a true limiter on revenue.
 








Perhaps...but the revenue growth was slowing long before any DEI initiatives. Marketing in pharma is severely curtailed by the FDA...approved claims only and all that. But more importantly, Vivitrol is only moderately effective for OUD and AUD in the real world...and prescribers know it. You can't market your way around what they experience.

Certainly DEI was a distraction....but from what?
What stellar marketing campaign got pushed aside for DEI?
What DTC campaign got pushed aside for DEI?
What detox kit got pushed aside for DEI?

Well...none. If DEI never existed ALKS would still be suffering from weak revenue growth. DEI is no more to blame for weak growth than the KAMs were. Both were rightly questioned and eventually curtailed\rejected...but neither was a true limiter on revenue.
Who cares about Vivitrol. Patent life coming to an end and sales have been flat for 6 quarters. Game over for that product in 12 months tops.
 








Who cares about Vivitrol. Patent life coming to an end and sales have been flat for 6 quarters. Game over for that product in 12 months tops.
Not sure why they haven't figured out how to extend the patent life with some configuration changes....seems like pharma companies do that all the time. Reformulate the microspheres to dissolve over an 8 week period....or longer. Look at all the different options for getting bup onboard...why not NLTXN?
 




Not sure why they haven't figured out how to extend the patent life with some configuration changes....seems like pharma companies do that all the time. Reformulate the microspheres to dissolve over an 8 week period....or longer. Look at all the different options for getting bup onboard...why not NLTXN?
Or expanded indications for other addictions, gambling, eating disorders…. Opportunity missed